Many experimental failures are not caused by a lack of significant differences, but rather by differences arising from unexpected sources. Knockdown observed in the negative control group, substantial variation in negative control results between different target genes, or the same siRNA becoming ineffective in a different cell type—these three phenomena point to the same issue: your control system and cellular model need to be re-evaluated. This article examines each of these problems in detail.

Why Untreated Cells Should Not Be Used as the Sole Baseline

Due to stimulation caused by transfection reagents or exogenous RNA, cells transfected with siRNA may exhibit gene expression profiles that differ from those of untreated cells. Therefore, a negative control (NC) must be included to account for these nonspecific effects. In other words, the purpose of the NC is to distinguish the effects caused by the transfection procedure itself from those specifically induced by the target siRNA.

Issue 1: Knockdown Is Also Observed in the Negative Control Group

If significant knockdown is also observed in the negative control group, it indicates that the baseline itself has shifted downward. Under these circumstances, the calculated knockdown efficiency of the target siRNA may be overestimated or even unreliable. The influence of the negative control can be minimized by addressing the following two factors:

1. Nonspecific effects of transfection reagents: Inappropriate transfection concentrations or reagent-induced cellular stimulation may lead to abnormal gene expression. Consider optimizing transfection conditions, such as reducing reagent concentrations or shortening the co-incubation time.

2. Unintended off-target effects of the control sequence: The negative control siRNA itself may inadvertently suppress the target gene. In this case, an alternative negative control siRNA should be used.

▎ How to Distinguish Between These Two Causes

Include both a mock-transfected group (transfection reagent only, without RNA) and an NC group (transfected with negative control siRNA). If the mock group already differs from the untreated group, the transfection reagent may be responsible. If the mock group shows normal expression while the NC group exhibits reduced expression, the negative control sequence itself may be the cause and should be replaced.

Issue 2: Large Differences in Negative Control Results Between Different Target Gene Groups

Under comparable experimental conditions, negative control results across groups are generally expected to be relatively consistent. If substantial deviations occur, the experimental procedures and accuracy of the measurements should be carefully reviewed, with particular attention to the following factors:

· Off-target effects

· Consistency of reagent concentrations

· Primer specificity

· Consistency in sample loading and experimental procedures

Another frequently overlooked biological factor is that different cell types may respond differently to external stimuli. Even when the same negative control siRNA is transfected, some cells may respond strongly to the transfection process, potentially causing changes in target gene expression. This is why control experiments should be conducted using the same batch, the same cell type, and identical treatment conditions to ensure meaningful comparisons.

Issue 3: The Same siRNA Produces Different Effects in Different Cell Types

This is a common and expected phenomenon. Different cell types vary in their signaling pathways, gene expression levels, and physiological characteristics. These differences can affect siRNA transfection efficiency, RNA degradation activity, and cellular responses following target gene knockdown. Consequently, the same siRNA may exhibit different levels of effectiveness across different cell types.

Therefore, an siRNA sequence and concentration that work well in a published study may not necessarily produce the same results in your specific cell model. The recommended approach is to revalidate the siRNA in your target cells before conducting formal experiments and select a sequence that achieves satisfactory target gene knockdown efficiency. There is no need to insist on reproducing the exact numerical values reported in the literature.

Control Group Setup Checklist

Important Reminder: The negative control (NC) should be processed in the same batch, at the same concentration, and under the same experimental conditions as the target siRNA. Each target gene should have an appropriately matched NC group. Data from a single NC group should not be indiscriminately used as the baseline for all genes, particularly when experimental conditions differ. Failure to maintain appropriately matched controls is one possible reason for large variations in NC results between different target gene groups.